Shannon E Munteanu1, Lisa A Scott1, Daniel R Bonanno1, Karl B Landorf1, Tania Pizzari2, Jill L Cook3, Hylton B Menz1. 1. Faculty of Health Sciences, Department of Podiatry, La Trobe University, Melbourne, Victoria, Australia Lower Extremity & Gait Studies Program, La Trobe University, Melbourne, Victoria, Australia. 2. Lower Extremity & Gait Studies Program, La Trobe University, Melbourne, Victoria, Australia Faculty of Health Sciences, Department of Physiotherapy, La Trobe University, Melbourne, Victoria, Australia. 3. Faculty of Medicine, Nursing & Health Sciences, Monash University, Melbourne, Victoria, Australia.
Abstract
AIM: To evaluate the effectiveness of customised foot orthoses in chronic mid-portion Achilles tendinopathy. METHODS: This was a participant-blinded, parallel-group randomised controlled trial at a single centre (La Trobe University, Melbourne, Australia). One hundred and forty participants aged 18-55 years with mid-portion Achilles tendinopathy were randomised to receive eccentric calf muscle exercises with either customised foot orthoses (intervention group) or sham foot orthoses (control group). Allocation to intervention was concealed. The Victorian Institute of Sports Assessment-Achilles (VISA-A) questionnaire was completed at baseline, then at 1, 3, 6 and 12 months, with 3 months being the primary end point. Differences between groups were analysed using intention to treat with analysis of covariance. RESULTS: After randomisation into the customised foot orthoses group (n=67) or sham foot orthoses group (n=73), there was 70.7% follow-up of participants at 3 months. There were no significant differences between groups at any time point. At 3 months, the mean (SD) VISA-A score was 82.1 (16.3) and 79.2 (20.0) points for the customised and sham foot orthosis groups, respectively (adjusted mean difference (95% CI)=2.6 (-2.9 to 8.0), p=0.353). There were no clinically meaningful differences between groups in any of the secondary outcome measures. CONCLUSIONS:Customised foot orthoses, prescribed according to the protocol in this study, are no more effective than sham foot orthoses for reducing symptoms and improving function in people with mid-portion Achillestendinopathy undergoing an eccentric calf muscle exercise programme. TRIAL REGISTRATION NUMBER: Australian New Zealand Clinical Trials Registry: number ACTRN12609000829213. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
RCT Entities:
AIM: To evaluate the effectiveness of customised foot orthoses in chronic mid-portion Achilles tendinopathy. METHODS: This was a participant-blinded, parallel-group randomised controlled trial at a single centre (La Trobe University, Melbourne, Australia). One hundred and forty participants aged 18-55 years with mid-portion Achilles tendinopathy were randomised to receive eccentric calf muscle exercises with either customised foot orthoses (intervention group) or sham foot orthoses (control group). Allocation to intervention was concealed. The Victorian Institute of Sports Assessment-Achilles (VISA-A) questionnaire was completed at baseline, then at 1, 3, 6 and 12 months, with 3 months being the primary end point. Differences between groups were analysed using intention to treat with analysis of covariance. RESULTS: After randomisation into the customised foot orthoses group (n=67) or sham foot orthoses group (n=73), there was 70.7% follow-up of participants at 3 months. There were no significant differences between groups at any time point. At 3 months, the mean (SD) VISA-A score was 82.1 (16.3) and 79.2 (20.0) points for the customised and sham foot orthosis groups, respectively (adjusted mean difference (95% CI)=2.6 (-2.9 to 8.0), p=0.353). There were no clinically meaningful differences between groups in any of the secondary outcome measures. CONCLUSIONS: Customised foot orthoses, prescribed according to the protocol in this study, are no more effective than sham foot orthoses for reducing symptoms and improving function in people with mid-portion Achilles tendinopathy undergoing an eccentric calf muscle exercise programme. TRIAL REGISTRATION NUMBER: Australian New Zealand Clinical Trials Registry: number ACTRN12609000829213. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: Karin Grävare Silbernagel; Peter Malliaras; Robert-Jan de Vos; Shawn Hanlon; Mitchel Molenaar; Håkan Alfredson; Inge van den Akker-Scheek; Jarrod Antflick; Mathijs van Ark; Kenneth Färnqvist; Zubair Haleem; Jean-Francois Kaux; Paul Kirwan; Bhavesh Kumar; Trevor Lewis; Adrian Mallows; Lorenzo Masci; Dylan Morrissey; Myles Murphy; Richard Newsham-West; Richard Norris; Seth O'Neill; Koen Peers; Igor Sancho; Kayla Seymore; Patrick Vallance; Arco van der Vlist; Bill Vicenzino Journal: Sports Med Date: 2021-11-19 Impact factor: 11.136
Authors: Shannon E Munteanu; Karl B Landorf; Jodie A McClelland; Edward Roddy; Flavia M Cicuttini; Alan Shiell; Maria Auhl; Jamie J Allan; Andrew K Buldt; Hylton B Menz Journal: Trials Date: 2017-04-27 Impact factor: 2.279
Authors: Chantel L Rabusin; Hylton B Menz; Jodie A McClelland; Angela M Evans; Karl B Landorf; Peter Malliaras; Sean I Docking; Shannon E Munteanu Journal: J Foot Ankle Res Date: 2019-03-21 Impact factor: 2.303
Authors: Natalie J Collins; Jade M Tan; Hylton B Menz; Trevor G Russell; Anne J Smith; Bill Vicenzino; Shannon E Munteanu; Rana S Hinman; Terry P Haines; Harvi F Hart; Brooke E Patterson; Gearoid Cleary; Joel W Donnar; Liam R Maclachlan; Kay M Crossley Journal: BMJ Open Date: 2019-04-20 Impact factor: 2.692
Authors: Daniel R Bonanno; George S Murley; Shannon E Munteanu; Karl B Landorf; Hylton B Menz Journal: J Foot Ankle Res Date: 2015-09-11 Impact factor: 2.303